PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22396207-4	2012	CR increased the protein level of AMPK-alpha2 and phosphorylation of AMPK-alpha2.	Chromium	0-2	protein kinase, AMP-activated, alpha 2 catalytic subunit	Mus musculus	34-45	
22396207-4	2012	CR increased the protein level of AMPK-alpha2 and phosphorylation of AMPK-alpha2.	Chromium	0-2	protein kinase, AMP-activated, alpha 2 catalytic subunit	Mus musculus	69-80	
22396207-5	2012	In WT and AMPK-alpha2(-/-) mice, CR induced comparable changes of body weight, fat pad weight, serum triglycerides, serum nonesterified fatty acids, and serum leptin levels.	Chromium	33-35	protein kinase, AMP-activated, alpha 2 catalytic subunit	Mus musculus	10-21	
22396207-7	2012	Moreover, CR-induced improvements of whole-body insulin sensitivity (evidenced by glucose tolerance test/insulin tolerance test assays) and glucose uptake in skeletal muscle tissues were abolished in AMPK-alpha2(-/-) mice.	Chromium	10-12	protein kinase, AMP-activated, alpha 2 catalytic subunit	Mus musculus	200-211	
22396207-9	2012	CR serum increased stability of AMPK-alpha2 protein via inhibiting the X chromosome-linked ubiquitin-specific protease 9-mediated ubiquitylation of AMPK-alpha2.	Chromium	0-2	protein kinase, AMP-activated, alpha 2 catalytic subunit	Mus musculus	32-43	
22396207-9	2012	CR serum increased stability of AMPK-alpha2 protein via inhibiting the X chromosome-linked ubiquitin-specific protease 9-mediated ubiquitylation of AMPK-alpha2.	Chromium	0-2	protein kinase, AMP-activated, alpha 2 catalytic subunit	Mus musculus	148-159